Papers Drug points Thromboembolism associated with the new contraceptive Yasmin BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7383.257 (Published 01 February 2003) Cite this as: BMJ 2003;326:257 Article Related content Metrics Responses Peer review Related articles Research The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b2921 Editorial Is an EMA review on hormonal contraception and thrombosis needed? Published: 07 March 2013; BMJ 346 doi:10.1136/bmj.f1464 See more US abortion: Supreme Court allows Texas to continue to ban emergency abortions BMJ October 10, 2024, 387 q2234; DOI: https://doi.org/10.1136/bmj.q2234 Surrogates have higher risk of pregnancy complications, research finds BMJ September 25, 2024, 386 q2100; DOI: https://doi.org/10.1136/bmj.q2100 Two thirds of maternity units fail to meet safety standards as poor care is “normalised,” says regulator BMJ September 19, 2024, 386 q2051; DOI: https://doi.org/10.1136/bmj.q2051 US women must be told breast density after mammogram, says FDA BMJ September 18, 2024, 386 q2045; DOI: https://doi.org/10.1136/bmj.q2045 Harris and Trump clash over abortion in presidential debate BMJ September 12, 2024, 386 q2003; DOI: https://doi.org/10.1136/bmj.q2003 Cited by... Is an EMA review on hormonal contraception and thrombosis needed?Fulltext PDF Computed Tomography of Pulmonary EmbolismFulltext PDF Abstract Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrelFulltext PDF Abstract The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control studyFulltext PDF Abstract
